Literature DB >> 33934057

Lenvatinib and osteonecrosis of the jaw: A pharmacovigilance study.

Wenchao Lu1, Qixiang Guo1, Zhuo Ma1, Lihong Liu2, Zhixia Zhao3.   

Abstract

Entities:  

Year:  2021        PMID: 33934057     DOI: 10.1016/j.ejca.2021.03.046

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

Review 1.  Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.

Authors:  L Lorusso; L Pieruzzi; M Gabriele; M Nisi; D Viola; E Molinaro; V Bottici; R Elisei; L Agate
Journal:  J Endocrinol Invest       Date:  2021-07-21       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.